Management of Diabetic complications (polyneuropathy)
Phase 2
- Conditions
- Health Condition 1: null- Diabetic polyneuropathy
- Registration Number
- CTRI/2017/07/009075
- Lead Sponsor
- Department Of Kayachikitsa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Metabolically stable type 2 diabetic patients with symptoms of diabetic sensory-motor Polyneuropathy
Exclusion Criteria
who are treated with Insulin.
Patients with other metabolic or endocrine disorders.
Patients with other causes of Polyneuropathy.
Patients suffering from infectious diseases.
Patient with non-healing ulcer/ulcers.
Patient with Disabling Diabetic Polyneuropathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method europathy Symptoms Score (NSS) Michigan Neuropathy Screening Instrument (MNSI)Timepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method scale for quality of life(WHO-QoL BREF)in diabetic neuropathy, Deha Bala, Agni Bala, and Chetas Bala.Timepoint: 8 weeks